India, Jan. 28 -- PharmEasy-owned diagnostics lab chain Thyrocare's consolidated net profit jumped 48.1% to INR 28.1 Cr in Q3 FY26 from INR 19 Cr in the same quarter last year. However, profit declined 41.4% sequentially from INR 47.8 Cr.

Revenue from operations grew 17.8% to INR 195.5 Cr from INR 165.9 Cr in Q3 FY25. On a QoQ basis, it declined 9.7% from INR 216.5 Cr.

Including other income of INR 5 Cr, total income stood at INR 200.5 Cr during the quarter under review.

Meanwhile, total expenses for the period stood at INR 159.2 Cr, up 12.2% from INR 141.9 Cr in the year-ago period.

(The story will be updated soon)

The post PharmEasy-Owned Thyrocare's Q3 Profit Jumps 48% To INR 28 Cr appeared first on Inc42 Media.

Published by HT D...